MedTrace Logo

High Doses Vitamin C and Tissular Repair in Surgical Patients

NCT04896359 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-10-04

No results posted yet for this study

Summary

This is a prospective, randomize, double-blind, and placebo-controlled study to evaluate in patients with clinical criteria for any of the following open surgical procedure: (1) cesarean section; (2) aesthetic surgery like abdominoplasty; (3) orthopedic surgery; and (4) abdominal open surgery \[excluding laparoscopic procedures\] will be invited to receive either a high dose of vitamin C (12.5 g) three times (48 h pre-surgery, immediately before surgery and 48 h post-surgery) or its placebo, to evaluate the tissue repair process using an international validated instrument named Patient and Observer Scar Assessment Scale.

Conditions

  • Tissue Damage

Interventions

DIETARY_SUPPLEMENT

Vitamin C

12.5 grams of ascorbic acid

OTHER

Placebo

vehicle

Sponsors & Collaborators

  • Biomolec Pharma

    collaborator UNKNOWN

  • Universidad San Francisco de Quito

    lead OTHER

Principal Investigators

  • Enrique Teran · Universidad San Francisco de Quito

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-15
Primary Completion
2021-03-03
Completion
2021-03-03

Countries

  • Ecuador

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04896359 on ClinicalTrials.gov